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Abstract--Uncovered fetal rabbit excisional wounds do not exhibit any classic signs 
of healing; wounds covered with an impermeable cover do contract, reepithelialize, 
and exhibit inflammation. Prostaglandin E z (PGE2) is elevated in amniotic fluid, 
acting as an immunosuppressant at the maternal-fetal interface. Full-thickness exci- 
sional wounds were made on 25-day gestational age rabbit fetuses. Half the wounds 
were covered with an impermeable cover. Tissue from covered, uncovered, and 
nonwounded fetuses was examined 72 h after wounding for arachidonic acid metab- 
olites. Uncovered wounds had significantly (P < 0.05) elevated levels of PGEz, 
PGF2~, and 12-HETE versus covered wounds and control tissue. Covered wounds 
had significantly elevated levels of 15-HETE compared to uncovered and control 
tissue. The elevated PGE2 in uncovered wounds may act as a fetal immunosuppres- 
sant; covered wounds (lower PGE2) developed cellular inflammation. Further inves- 
tigations of these interz.ctions may permit modulation of adult inflammation. 
I N T R O D U C T I O N  
Fetal  w o u n d s  exhib i t  s ignif icant ly different  heal ing  character is t ics  than postpar-  
tum wounds .  Sutured incis ional  fetal wounds  heal wi th  no vis ible  scar  format ion ,  
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whi le  excis ional  fetal rabbit  w o u n d s  exposed  to amniot ic  fluid apparent ly  do not  
heal ,  d i sp lay ing  no in f lammat ion ,  contract ion,  or  reepi thel ia l izat ion (1-6) .  H o w -  
ever ,  cove rage  o f  fetal rabbit  excis ional  w o u n d s  wi th  an impe rmeab le  m e m b r a n e  
that  exc ludes  amnio t ic  fluid does  a l low a cel lular  in f lammatory  response ,  w o u n d  
cont rac t ion ,  and reepi thel ia l iza t ion (7-9) .  
A m nio t i c  fluid conta ins  e leva ted  levels  o f  a rachidonic  acid metabol i tes ,  
par t icular ly p ros tag land ins  (PG),  wh ich  are k n o w n  to be  potent  inf lammatory  
media to rs  (10-12) .  The  e leva ted  levels  o f  PGE2 found in amniot ic  fluid are 
thought  to act as i m m u n o s u p p r e s s a n t s  at the ma te rna l - fe t a l  interface to prevent  
re ject ion (13-d8) .  This  s tudy was  des igned  to examine  the levels  o f  various 
a rachidonic  acid metabol i tes  (e icosanoids)  in fetal t issue sur rounding  covered  
and uncove red  exc is iona l  wounds ,  correla t ing the data to cel lular  inf lammation.  
M A T E R I A L S  A N D  M E T H O D S  
Surgery and Sample Procurement. Time-dated pregnant New Zealand White rabbits were 
procured on day 20 of gestation (term = 31-32 days). The rabbits were allowed to recover from 
the stress of tmnsport~ On day 25, the does were anesthetized by intramuscular administration of 
xylazine (Rompun, 12 mg/kg), ketamine (60 mg/kg), and acepromazine (0.6 mg/kg). One percent 
halothane was administered by mask for maintenance and uterine relaxation during the procedure. 
Halothane exposure was limited to 1 h to minimize fetal mortality. 
The bicornate uterus was exposed through a midline laparotomy, and the distal (ovary end) 
two fetuses were identified in each horn for surgery. The tail and dorsal hindquarters of the fetus 
were gently exposed through individual purse string hysterotomies, with the hind legs remaining 
within the confines of the uterus. A 4-mm-diameter punch wound, inclusive of the panniculus 
carnosus, was created on the dorsal midline immediately cranial to the tail of the fetus. Following 
creation of the defect, fetuses were divided into one of two groups: group 1 fetuses were returned 
to the uterus with no further manipulation (uncovered control) (N = 8); group 2 fetuses were 
stabilized to allow a 6-mm-diameter impermeable silicone cover to be sutured over the defect with 
six 7-0 prolene sutures before being returned to the uterus (covered) (N = 8). Six-millimeter- 
diameter covers were utilized, as covers larger than 6 mrn buckled on the curved dorsum of the 
animal, creating a conduit to the wound. Sham controls included a nonwounded fetus exposed to 
air and returned to the uterus, a nonwounded fetus that had a cover sutured in place, and a fetus in 
which the silicone cover was placed subcutaneously and the incision sutured closed with 7-0 prolene. 
Sterile saline (37~ was added to replace lost amniotic fluid (approx. 1-2 ml). The does were 
returned to their cages and allowed to recover. Food and water were supplied ad libitum. 
Fetuses were harvested by cesarian section at 72 h after wounding. The wounds were pho- 
tographed and the surface area of the wounds was calculated by planimetry. The dorsal operated 
area was excised; half the fetuses were fixed in 10% buffered formalin for histologic analysis and 
half were flash frozen in liquid nitrogen and stored at -70~ for determination of inflammatory 
mediators. Dorsal skin for nonexposed, nonwounded fetuses was excised and flash frozen to serve 
as control samples for eicosanoid analysis (N = 4). The frozen tissue from the initial two fetuses 
in each group were combined to ensure measurable levels of eicosanoids. The remaining two fetuses 
from each group were processed individually. Amniotic fluid from around two nonoperated fetuses 
were collected at harvest, pooled, and analyzed for eicosanoid levels. 
Arachidonic Acid Metabolites (Eicosanoid) Quantification. Presence and quantities of 
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inflammatory mediators proslaglandins (PGE2, PGF2~), leukotrienes (LTB4, LTC4, and LTD4), and 
hydroxyeicosatetraenoic acid:; (12-and 15-HETE) were determined following the procedure of Duell 
et al. (19). Briefly, the frozen sections were weighed and then powdered under liquid nitrogen in a 
precooled mortar and pestle While still frozen, the powder was transferred to a polypropylene 
centrifuge tube containing 4 ml of extraction solution (8 parts ethanol to 2 parts 0.01 M phosphate 
buffer, pH 6.4). The extmcti,)n solution prevents further synthesis or hydrolysis of the eicosanoids. 
The samples were stirred on ice for 30 min, followed by centrifugation at 2500 g for 10 min. The 
supematant was saved. The pellets were reextracted for 30 min with 2 ml of ethanol-methanol- 
buffer (4:4:2)  and recentrifaged. The supematants were combined, and buffer added to reduce 
alcohol content to 15%. 
The combined supernatant fractions and amniotic fluid were partially purified with conditioned 
Sep-pak cartridges, washed with hexane, and the eicosanoids eluted with methyl formate and meth- 
anol. The methyl formate ard methanol fractions were evaporated to dryness under nitrogen and 
resuspended in a final volurae of 30 /zl (8:2) of acetonitrile and H20 containing 0.2% H2PO4 
adjusted to pH 3.9 with NH4OH. 
The eicosanoids were ~eparated using a modification of the HPLC method of Van Rollins et 
al. (20). Briefly, HPLC separations were done using a Hewlett-Packard 1090 M unit equipped with 
a ternary solvent system, diode army detector, and sample oven. Twenty-five microliters of each 
sample were injected onto a Hewlett-Packard C~8-ODS microbore column (100 mm • 2.1 mm). 
A flow rate of 0.3 ml/min a~: 38~ was used for the 30-rain analysis. The initial solvent was 30 
parts acetonitrile-70 parts w~Ier containing 0.2 % phosphoric acid adjusted to pH 3.9 with ammo- 
nium hydroxide. After 6 rain of isocratic elution, an acetonitrile gradient was initiated that reaches 
50% at 15 min. During the next 5 rain the acetonitrile concentration was increased to 55 %, followed 
by an increase to 85 % in the next 3 min. At 25 min the acetonitrile concentration was lowered to 
65 % to prevent precipitation of ammonium phosphate at high acetonitrile concentrations and still 
clear the column of noneicosanoid lipids. The fractions were evaporated to dryness under a stream 
of nitrogen and the residues resuspended in 200/zl of the appropriate buffer. 
The mediators (PGs, LTs, HETEs) were quantified by RIA. The HPLC HETE samples were 
assayed at three dilutions in 0.01 M phosphate buffer, pH 7.6, 0.9% NaC1, 0.1% BSA, and 0.1% 
sodium azide. Appropriate ttitiated mediator was added as labeled antigen. Total volume of the 
assay was 300 #1. The standard curve ranged from 10 to 400 pg/tube. The samples were incubated 
at room temperature for 2 h. The assay was terminated by addition of 700 ~tl of ice-cold dextran- 
coated charcoal. Samples were kept on ice for 10 min, then centrifuged at 2500 g for 10 min. The 
supematant fractions were transferred to scintillation vials and counted. The results are expressed 
as picograms per milligram oi~ protein or picograms per milligram of DNA. The assay for LTs and 
PGs was similar, utilizing a slightly different pH and was run overnight at 4~ 
Protein levels of the tissue were determined by the methods of Lowry et al. (21). DNA 
concentration in the tissue was determined by the method of Burton (22). 
Statistical Analysis. A one-way analysis of variance (ANOVA) was performed to determine 
significance between uncovered, covered, and control (nonoperated) tissue levels at P < 0.05. 
R E S U L T S  
U n c o v e r e d  w o u n d s  e x h i b i t e d  a v e r y  s p a r s e  c e l l u l a r  i n f l a m m a t o r y  r e s p o n s e .  
S i l i c o n e - c o v e r e d  w o u n d s  e x h i b i t e d  a m a r k e d ,  m i x e d  ce l l u l a r  i n f l a m m a t o r y  
r e s p o n s e  o f  h i s t i o c y t e s ,  m o r l o c y t e s ,  m a c r o p h a g e s ,  a n d  p o l y m o r p h o n u c l e a r  leu-  
k o c y t e s .  T h e  i n f l a m m a t o r y  ce l l s  w e r e  p r e s e n t  t h r o u g h o u t  t he  s u b c u t a n e o u s  t i s sue  
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under the wound and in the coagulum under the cover. Inflammatory cells were 
rarely found in the subcutaneous tissue under the nonwounded tissue surrounding 
the defect. Using the edge of the dermal tissue as reference, all covered wounds 
exhibited varying degrees of contraction (mean = 69% original size), while 
uncovered wounds increased in surface area (mean = 139% original area). 
Examination of the sham controls showed no gross or histologic changes 
when compared to skin of normal, nonexposed, nonoperated rabbit fetuses of 
the same gestational age. A few inflammatory cells were noted around the suture 
used to affix the silicone cover to the fetus. A very mild foreign-body reaction 
was noted around the silicone cover placed subcutaneously. 
Analysis of tissue samples encompassing uncovered wounds showed sig- 
nificantly elevated levels of PGE2, PGF2,, and 12-HETE compared to covered 
wounds and control tissue (Table 1, Figure 1). LTB 4 levels in uncovered wounds 
were significantly higher than covered wounds and nonoperated skin. Covered 
wounds exhibited significantly elevated levels of 15-HETE compared to uncov- 
ered and control samples, and significantly elevated levels of PGF2~ compared 
to control tissue. Overall, the leukotriene pathway of the eicosanoid biosynthetic 
pathway was suppressed for all tissue samples. Amniotic fluid levels of eico- 
sanoids were elevated for all eicosanoids with the exception of LTD4, which 
was at background levels. 
DISCUSSION 
The response of the fetus to surgical insult is becoming increasingly impor- 
tant due to the expanding number of invasive procedures performed on fetuses. 
These procedures range from accidental trauma (misguided amniocentesis sticks) 
to in utero procedures (fetal blood transfusions, biopsies, and skin sampling) to 
direct surgical intervention for life-threatening anomalies (distal urinary tract 
obstructions and diaphragmatic hernia) (23-28). The sequelae to these proce- 
dures are represented in this study: uncovered wounds are similar to needle 
sticks and fetal skin sampling; covered wounds are similar to diaphragmatic 
hernia repair, in which a Gortex patch is sutured to the abdominal wall and 
prevents amniotic fluid from entering the abdominal cavity. 
The lack of a cellular inflammatory response for uncovered (amniotic fluid- 
exposed) fetal excisional wounds initially appears paradoxical, as fetuses are 
capable of mounting a cellular inflammatory response to bacterial and chemical 
challenges and also to thermal burns (29-34). However, the situations in which 
the fetus can mount an inflammatory response (bacterial and chemical chal- 
lenges, burns with intact eschar) are closed insults, protected from amniotic 
fluid. This is in contrast to open, uncovered excisional wounds, which are 
Arachidonic Acid Metabolites 
Table 1. Levels of Eicosanoids in Tissue Samples from Uncovered, Covered, and Control 
(Nonoperated) Fetuses 72 Hours after Wounding (Mean + SEM) 
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Level (pg//,tg DNA) 




PGE2 14.20 _ 7.39 ~ 4.43 • 1.29 3.37 + 1.55 565.6 
PGF2~ 4.68 ___ 2.46 ~ 1.58 • 0.65 0.67 + 0.16 457.8 
LTB 4 0.66 • 3.38 a 0.37 • 0.18 0.05 • 0.03 92.41 
LTC4 b b b 332.8 
LTD4 b b b b 
15-HETE 17.95 • '5.63 28.35 • 4.62 c 11.99 • 3.37 2420.0 
12-HETE 18.25 • ,5.67 a 5.38 + 2.22 7.60 • 5.02 706,5 
aSignificantly higher than covered at P < 0.05. 
bBackground levels. 
r higher than uncovered at P _< 0.05. 
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1 0 - -  
0 
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Fig. 1. Bar graph of levels of PGF2~, PGE2, 15-HETE, and 12-HETE in uncovered and covered 
fetal wound tissue and in nonoperated control tissue. 
cont inuously  bathed by amniot ic  fluid and do not mount  an inf lammatory 
response.  The  fetal in f lammatory  response seen here for  covered  wounds  con- 
f inns prev ious ly  reported results (9). 
Amnio t i c  fluid contains  e levated levels  o f  PGE2, which functions at the 
mate rna l - fe ta l  interface to prevent  maternal  (host) reject ion o f  the foreign fetal 
t issue (13-18) .  PGE2 has also been  shown to inhibit  contract ion o f  fibroblast- 
popula ted  co l lagen  lattices in cul ture (35). Thus the PGE2 in amniot ic  fluid may 
also inhibit  contract ion o f  fetal wounds ,  with the covers  exc luding  PGF~ and 
resul t ing in wound  cont :act ion.  
Addi t iona l  arachidonic  acid metabol i tes  are present  in amniot ic  fluid and 
are known to be  potent  inf lammatory  and contract i le  mediators  (17). The  sig- 
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nificantly elevated levels of PGE 2 in the tissue surrounding uncovered fetal rabbit 
wounds may suppress the fetus' ability to mount an inflammatory response, 
while the lower levels in covered wounds may permit a response. These quan- 
titative data, along with the histologic evidence, supports the theory that inhib- 
itory or suppressive factors are present in amniotic fluid and can affect the fetus' 
response to insult. 
The suppression of the leukotfiene portion of the arachidonic acid metabolic 
pathway deserves further comment. The HPETE and HETE families of mole- 
cules have potent chemotactic activity for eosinophils and neutrophils (10). As 
such, the marked cellular inflammation of covered wounds is not unexpected 
when the elevated levels of 15-HETE in covered wounds is considered. The 
leukotrienes are chemotactic for polymorphonuclear leukocytes and cause release 
of lysosomal enzymes from PMNs (36). Additionally, LTs are closely related 
(or identical) to "slow-reacting substance" (SRS) (which possesses smooth mus- 
cle contracting activity), with LTD4 being the most potent (10). The general 
suppression of the leukotriene family may be related to the lack of wound 
contraction in uncovered wounds, but the lack of leukotrienes (especially LTD4) 
in covered wounds and nonwounded skin seems to refute any role leukotrienes 
may play in covered fetal wound contraction. It is possible that there are un- 
identified factors present in the fetal milieu that suppress leukotriene production, 
or perhaps fetuses of this age have not developed the capability to synthesize 
leukotrienes. 
Further investigations into the relationship between the fetal response fol- 
lowing excisional wounding and factors present in amniotic fluid may elucidate 
the roles these factors play in inflammation and healing. This knowledge has 
significant ramifications regarding modulation of the inflammatory response, 
future fetal surgery, and potentially may be used to modify abnormal adult 
inflammation and healing. 
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